INCORRECT ROUTE OF PRODUCT ADMINISTRATION

This adverse event was reported 17161 times

These drugs are most commonly taken by patients reporting INCORRECT ROUTE OF PRODUCT ADMINISTRATION:

# Drug Count
0 TIOTROPIUM BROMIDE 1153
1 METHOTREXATE SODIUM 1132
2 ACETAMINOPHEN 1019
3 DUPILUMAB 1007
4 METHOTREXATE 1006
5 PREDNISONE 991
6 ADALIMUMAB 928
7 DICLOFENAC SODIUM 845
8 ACETAMINOPHEN 500MG 825
9 ACETAMINOPHEN TABLET EXTENDED RELEASE 825
See all common drugs associated with INCORRECT ROUTE OF PRODUCT ADMINISTRATION

INCORRECT ROUTE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMMONIUM CHLORIDE 92 0.3680
1 ASIAN GINSENG 106 0.2512
2 SODIUM CITRATE 132 0.1051
3 NATAMYCIN 42 0.1024
4 DEXTROSE AND SODIUM CHLORIDE 16 0.0958
5 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 28 0.0912
6 CAFFEINE CITRATE 171 0.0733
7 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 45 0.0684
8 TRIPROLIDINE HYDROCHLORIDE 13 0.0667
9 DOBUTAMINE HYDROCHLORIDE 81 0.0625
See all drugs enriched for association with INCORRECT ROUTE OF PRODUCT ADMINISTRATION

INCORRECT ROUTE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Polyene Antimicrobial [EPC] 42 0.1024
1 Skin Test Antigen [EPC] 86 0.0456
2 Endoglycosidase [EPC] 58 0.0313
3 Osmotic Diuretic [EPC] 117 0.0224
4 Vitamin K [EPC] 178 0.0206
5 Human Immunoglobulin [EPC] 1 0.0196
6 Antithrombin-directed RNA Interaction [EPC] 1 0.0179
7 Provitamin D2 Compound [EPC] 410 0.0138
8 Lead Chelator [EPC] 1 0.0119
9 Parenteral Iron Replacement [EPC] 147 0.0107
See all drug classes enriched for association with INCORRECT ROUTE OF PRODUCT ADMINISTRATION